Medical devices, healthcare technology and the business of care
510(k) clearance · K262052

Tri Stage Venous Cannulae

Sorin Group Italia S.R.L. · Decision date Sep 28, 2026

MEDTECHLEDGER EXPLANATIONK262052

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-28 for K262052, Tri Stage Venous Cannulae, submitted by Sorin Group Italia S.R.L. of Mirandola, Italy. The device falls under regulation 870.4210, product code DWF, device class 2, in the cardiovascular specialty, with the classification name Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass. The application was received 06/18/2026 and is listed as a traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan.

SESE indicates 510(k) clearance rather than PMA approval. The TPLC listing places K262052 among Sorin Group Italia's premarket reviews for this regulation, alongside entries such as K253671 Dual Stage Venous Cannulae and K263092 Dual Stage Venous Cannulae. The source does not include a summary statement, so the specific design features distinguishing the tri stage configuration, its indications, and any performance data remain unknown from these records.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 28, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262052
Regulatory pathway
510(k) premarket notification
Product code
DWF
Decision code
SESE
Decision date
Sep 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass.

Product code
DWF
FDA device class
2

FDA decision timeline

  1. K262052 received

    Application receipt date recorded by FDA.

  2. K262052 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DWF

Product / regulatory recordCompanyPathwayDecision dateSource
AngioDynamics, Inc.510(k) clearanceOct 30, 2026FDA
Medtronic, Inc.510(k) clearanceOct 29, 2026FDA
Sorin Group Italia S.R.L.510(k) clearanceOct 1, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Sorin Group Italia S.R.L.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Mirandola

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records